Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBoundless Bio, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.73 | -$0.73 | -$0.73 |
| Q2 2025 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q3 2025 | 1 | -$0.83 | -$0.83 | -$0.83 |
| Q4 2025 | 1 | -$0.88 | -$0.88 | -$0.88 |
Boundless Bio, Inc. Common Stock Earnings Date And Information
Boundless Bio, Inc. Common Stock last posted its earnings results on Thursday, March 13th, 2025. The company reported $-0.74 earnings per share for the quarter, missing analysts' consensus estimates of $-0.74 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Boundless Bio, Inc. Common Stock has generated $-2 earnings per share over the last year ($-2.22 diluted earnings per share) and currently has a price-to-earnings ratio of -0.62. Boundless Bio, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Boundless Bio, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | N/A | -$0.74 | N/A | $0 | $0 |
| 06/28/2024 | Q2 2024 | N/A | -$0.77 | N/A | $0 | $0 |
| 03/29/2024 | Q1 2024 | N/A | -$0.69 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$0.55 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.59 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.56 | N/A | N/A | $0 |
| 03/29/2023 | Q1 2023 | N/A | -$0.53 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.53 | N/A | N/A | $0 |
| 09/28/2022 | Q3 2022 | N/A | -$0.59 | N/A | N/A | $0 |
| 11/07/2019 | Q3 2019 | -$1.07 | -$3.14 | -2.07 | N/A | $0 |
| 08/06/2019 | Q2 2019 | N/A | -$2.14 | N/A | N/A | $0 |
| 05/07/2019 | Q1 2019 | N/A | -$1.12 | N/A | N/A | $0 |
| 03/01/2019 | Q4 2018 | N/A | -$2.93 | N/A | N/A | $0 |
| 11/06/2018 | Q3 2018 | N/A | -$2.12 | N/A | N/A | $0 |
| 08/06/2018 | Q2 2018 | -$0.78 | -$1.29 | -0.51 | N/A | $0 |
| 05/10/2018 | Q1 2018 | N/A | -$0.58 | N/A | N/A | $0 |
| 03/09/2018 | Q4 2017 | N/A | -$2.05 | N/A | N/A | $0 |
| 11/14/2017 | Q3 2017 | -$0.89 | -$1.50 | -0.61 | N/A | $0 |
| 08/10/2017 | Q2 2017 | -$0.79 | -$0.93 | -0.14 | N/A | $0 |
| 05/11/2017 | Q1 2017 | -$0.92 | -$0.41 | 0.51 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Boundless Bio, Inc. Common Stock Earnings: FAQ's
Boundless Bio, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based offlast year's report dates.
The conference call for Boundless Bio, Inc. Common Stock's latest earnings report can be listened to online.
The conference call transcript for Boundless Bio, Inc. Common Stock's latest earnings report can be read online.
Boundless Bio, Inc. Common Stock (:BOLD) has a recorded net income of $-49,434,000.Boundless Bio, Inc. Common Stock has generated $-2.22 earnings per share over the last four quarters.
Boundless Bio, Inc. Common Stock (:BOLD) has a price-to-earnings ratio of -0.62 and price/earnings-to-growth ratio is 0.11.